Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: the Australian Trial in Acute Hepatitis C

BACKGROUND: A barrier to hepatitis C virus (HCV) treatment among people who inject drugs (PWID) has been a concern that interferon-based HCV treatment may increase injecting risk behaviours. This study evaluated recent (past month) injecting risk behaviours during follow-up among PWID that did and d...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Int J Drug Policy
Hoofdauteurs: Alavi, Maryam, Spelman, Tim, Matthews, Gail V., Haber, Paul S., Day, Carolyn, van Beek, Ingrid, Walsh, Nick, Yeung, Barbara, Bruneau, Julie, Petoumenos, Kathy, Dolan, Kate, Kaldor, John M., Dore, Gregory J, Hellard, Margaret, Grebely, Jason
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2015
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4577441/
https://ncbi.nlm.nih.gov/pubmed/26115881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugpo.2015.05.003
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items